Company Overview and News


Add MYGN
to your dashboard

Headline News

Medtronic Wins FDA Nod for Azure Pacemakers, Grows in CVG

13h zacks
Medtronic plc (MDT - Free Report) announced the receipt of FDA approval and commercial launch of its portfolio of Azure pacemakers with BlueSync technology. According to the company, this technology enables secure, automatic and wireless remote monitoring via the Medtronic CareLink Network. Security controls implemented and validated on BlueSync-enabled devices include access restrictions to protect integrity of device functionality and end-to-end encryption to protect patient data. (36-1)

DENTSPLY SIRONA Strong on Deal Renewals, Forex Woes Stay

16h zacks
On Nov 20, we issued an updated research report on DENTSPLY SIRONA Inc. (XRAY - Free Report) — a global leader in the design, development, manufacture and marketing of dental consumables and dental laboratory products. (50-0)

McKesson Gains From Distribution Business Amid Pricing Woes

17h zacks
On Nov 20, we issued an updated research report on San Francisco, CA-based McKesson Corporation (MCK - Free Report) , a health care services and information technology company. (48-0)

Haemonetics (HAE) at 52-Week High: What's Driving the Stock?

2017-11-20 zacks
Shares of Haemonetics Corporation (HAE - Free Report) scaled a new 52-week high of $58.02 on Nov 17, closing nominally lower at $57.99. The company has gained 43.9% in the last six months, much higher than the S&P 500’s gain of 7.8%. Haemonetics has also beat the broader industry’s gain of 7.3%. The stock has a market cap of $3.06 billion. (40-1)

AmerisourceBergen's PharMEDium Slows Down, Competition Rife

2017-11-20 zacks
On Nov 17, we issued an updated research report on Chesterbrook, PA-based AmerisourceBergen Corporation (ABC - Free Report) , one of the world’s largest pharmaceutical services companies. The company focuses on providing drug distribution and related services to reduce health care costs and improve patient outcome. (57-0)

Varian's Halcyon Receives Shonin Approval, Grows in Oncology

2017-11-20 zacks
Varian Medical Systems (VAR - Free Report) announced the receipt of Shonin approval from the Ministry of Health, Labor and Welfare (MHLW) to market the Varian Halcyon system. The new system designed for cancer treatment simplifies and improves almost every aspect of image-guided volumetric intensity modulated radiotherapy (IMRT). (35-0)

Wright Medical (WMGI) Rides on Strong Portfolio & Innovation

2017-11-20 zacks
On Nov 17, we issued an updated research report on Wright Medical Group N.V. (WMGI - Free Report) . The company recently reported third-quarter results, wherein adjusted earnings were in line with the Zacks Consensus Estimate. Exclusive platforms and technologies like PERFORM Reversed glenoid, ORTHOLOC 3Di and the SIMPLICITI shoulder system were key catalysts in the third quarter. (31-0)

Intuitive Surgical Hits a 52-Week High on Solid Prospects

2017-11-20 zacks
Share price of Intuitive Surgical Inc (ISRG - Free Report) scaled a new 52-week high of $400 on Nov 17, eventually closing a bit lower at $392.48. The company has gained 19.8% over the last three months, much better than the S&P 500’s 6.4% rise and the broader industry’s gain of 6.3%. Taking the stock’s stable performance into consideration, we expect Intuitive Surgical to scale higher in the coming quarters. (31-0)

Genomic Health Cancer Diagnostic Tests Grow Amid Cost Woes

2017-11-17 zacks
On Nov 15, we issued an updated research report on Genomic Health Inc (GHDX - Free Report) , a global cancer research company with focus on advanced molecular diagnostics. (35-1)

Medtronic Stock Dips on Preliminary Sales Drag, CRHF to Grow

2017-11-17 zacks
On Nov 17, 2017, we issued an updated research report on medical device major, Medtronic plc (MDT - Free Report) . The stock carries a Zacks Rank #4 (Sell). (61-0)

Luminex (LMNX) Banks on FDA Approvals & Portfolio Strength

2017-11-16 zacks
On Nov 16, we issued an updated research report on Luminex Corp (LMNX - Free Report) — a manufacturer and marketer of proprietary biological testing technologies with applications throughout the life sciences and diagnostics industry. (47-0)

Sangamo Therapeutics (SGMO) in Focus: Stock Moves 13.6% Higher

2017-11-16 zacks
Sangamo Therapeutics, Inc. (SGMO - Free Report) was a big mover last session, as the company saw its shares rise nearly 14% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $11.60 to $14.50 in the past one-month time frame. (15-0)

Lexicon (LXRX) Looks Good: Stock Adds 7.6% in Session

2017-11-16 zacks
Lexicon Pharmaceuticals, Inc. (LXRX - Free Report) was a big mover last session, as the company saw its shares rise more than 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $8.77 to $9.81 in the past one-month time frame. The company has seen two positive estimate revisions in the past one month, while its Zacks Consensus Estimate has also moved higher over the said time frame, suggesting that more solid trading could be ahead for Lexicon. (26-0)

Here's Why Investors Should Buy Myriad Genetics Right Now

2017-11-16 zacks
Myriad Genetics, Inc. (MYGN - Free Report) has rallied 12.2% over the last three months, ahead of the S&P 500’s 6.3% gain and also better than the broader industry’s decline of 4.6%. The stock has a market cap of $2.16 billion. (44-1)

Illumina Introduces NextSeq 550Dx, Updates Use of MiSeqDx

2017-11-16 zacks
Illumina, Inc. (ILMN - Free Report) recently introduced its second FDA-regulated and CE-IVD marked next-generation sequencing (NGS) system — NextSeq 550Dx. The instrument has been designed to deliver the power of high-throughput NGS to the clinical laboratory. (55-0)

CUSIP: 62855J904